Purchase Order N0016810P4631

This is a firm fixed price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the supply of APTIMA COMBO 2, 250-TEST KIT, PANTHER. The order has a potential value of $855,500.00 and was awarded on October 1, 2018, with a completion date of July 9, 2019. The place of performance is Marlborough, MA. This contract is not designated as a set-aside. Gen-Probe Incorporated, through its Gen-Probe Sales...

This is a $15,210.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Altona Diagnostics USA Inc., a foreign-owned for-profit organization. The contract is for the delivery of in vitro diagnostic tests, reagents, and PCR-related products used for the detection of pathogens. This award does not have a set-aside designation. Altona Diagnostics USA Inc. has previously received other contracts from the CDC, including the supply of MPOX (monkeypox)...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a for-profit medical diagnostics company, for $56,000.00. The contract is for the PANTHER FUSION STANDARD SERVICE, a molecular diagnostic testing system and related products and services. Gen-Probe has held numerous contracts with defense and civilian agencies to supply testing kits, reagents, and equipment for detecting infectious diseases such as HIV,...

This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The award was made to Personal Diagnostix Inc., a minority-owned, self-certified small disadvantaged business, for the provision of 12 custom PCR assays on viral RNA samples at $120 each, for a total ceiling value of $10,440.00. The contract was issued as a firm fixed price purchase order with a period of...

This is a federal delivery order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the Department of the Navy, to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the procurement of APTIMA COMBO 2, 250-test kits for the PANTHER diagnostic system, which are used for high-throughput nucleic acid testing in clinical laboratories. The $171,012.50 firm fixed-price contract has a period of performance through May 27, 2016. Gen-Probe is a key...

This is a Firm Fixed Price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, on March 7, 2018. The order is for 250-test kits of the APTIMA COMBO 2 assay and PANTHER systems, which are used to detect chlamydia and gonorrhea infections. The potential value of the award is $148,500.00. This delivery order is not associated with a set-aside program. Gen-Probe Incorporated has a history of providing...

This is a firm fixed-price delivery order awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the supply of 250-test APTIMA COMBO 2 kits and PANTHER systems. The order has a potential value of $148,550.00 and a completion date of December 15, 2017. The contract does not have a set-aside designation. Gen-Probe Incorporated has a history of providing a variety of medical diagnostics products and services, including...

This is a federal Delivery Order awarded by the Defense Health Agency to Immucor Inc., a manufacturer of in vitro diagnostic products and blood banking supplies. The contract, valued at $8,745.07, is for the provision of PANOCELL 16 16X3 products, which are likely reagents or test kits used in blood typing and compatibility testing. The contract is issued under Immucor's existing General Services Administration (GSA) Multiple Award Schedule contract for In Vitro Diagnostics, Reagents, and Test...

This is a firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Diasorin Deutschland GMBH, a foreign-owned for-profit manufacturer of goods. The contract is for the delivery of RPP NXTAG (IVD-US) 96 tests, with a ceiling value of $146,514.23 and an ultimate completion date of September 4, 2024. The contract is not set aside and was awarded on September 5, 2023. This appears to be a standalone contract award and not associated with a larger contract vehicle.

This is a $96,195.84 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Luminex Corp, a manufacturer of biological testing technologies, for the procurement of 24 units of the NxTAG Respiratory Pathogen Panel + SARS-CoV-2 test kits. The contract supports the Naval Health Research Center's (NHRC) laboratory testing requirements in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C....